PT1300401E - Derivados de tiazole para utilização como anti-inflamatórios - Google Patents
Derivados de tiazole para utilização como anti-inflamatórios Download PDFInfo
- Publication number
- PT1300401E PT1300401E PT01943850T PT01943850T PT1300401E PT 1300401 E PT1300401 E PT 1300401E PT 01943850 T PT01943850 T PT 01943850T PT 01943850 T PT01943850 T PT 01943850T PT 1300401 E PT1300401 E PT 1300401E
- Authority
- PT
- Portugal
- Prior art keywords
- substituted
- unsubstituted
- hydrogen
- antiinflammatories
- unsubstituted alkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Transplantation (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000198074 | 2000-06-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1300401E true PT1300401E (pt) | 2010-01-25 |
Family
ID=18696291
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT01943850T PT1300401E (pt) | 2000-06-30 | 2001-06-28 | Derivados de tiazole para utilização como anti-inflamatórios |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US6919361B2 (pt) |
| EP (2) | EP1669070A3 (pt) |
| JP (1) | JP3785397B2 (pt) |
| KR (2) | KR100824156B1 (pt) |
| CN (2) | CN100369903C (pt) |
| AT (1) | ATE451102T1 (pt) |
| AU (2) | AU6634501A (pt) |
| CA (1) | CA2413000C (pt) |
| CY (1) | CY1109863T1 (pt) |
| DE (1) | DE60140748D1 (pt) |
| DK (1) | DK1300401T3 (pt) |
| ES (1) | ES2336425T3 (pt) |
| PT (1) | PT1300401E (pt) |
| TW (1) | TWI313266B (pt) |
| WO (1) | WO2002002542A1 (pt) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003057693A1 (fr) * | 2001-12-28 | 2003-07-17 | Sumitomo Pharmaceuticals Co., Ltd. | Composes cycliques a 5 chainons |
| EP1348433A1 (en) * | 2002-03-28 | 2003-10-01 | Warner-Lambert Company LLC | Thiazol-2-yl-imine compounds as PDE-7 inhibitors |
| DE10254336A1 (de) * | 2002-11-21 | 2004-06-03 | Merck Patent Gmbh | Carbonsäureamide |
| US20070105908A1 (en) * | 2003-06-27 | 2007-05-10 | Dainippon Sumitomo Pharma Co., Ltd. | Thiazolimine compound and oxazolimine compound |
| EP2204805B1 (en) * | 2003-10-10 | 2012-06-06 | Sharp Kabushiki Kaisha | A content reproducing apparatus, a content recording medium, a control program and a computer-readable recording medium |
| MY162179A (en) * | 2004-04-01 | 2017-05-31 | Elan Pharm Inc | Steroid sparing agents and methods of using same |
| RU2007122351A (ru) * | 2004-11-15 | 2008-12-20 | Тайсо Фармасьютикал Ко. | Иминовое соединение |
| US8012971B2 (en) * | 2005-04-28 | 2011-09-06 | Dainippon Sumitomo Pharma Co., Ltd. | Therapeutic agent for chronic obstructive pulmonary disease |
| JP2007015999A (ja) * | 2005-07-11 | 2007-01-25 | Sumitomo Chemical Co Ltd | イミノチアゾール化合物の製造方法 |
| KR20090013825A (ko) * | 2006-05-11 | 2009-02-05 | 다이닛본 스미토모 세이야꾸 가부시끼가이샤 | 활성 성분으로서 티아졸 유도체를 함유하는 약제 |
| CA2647598A1 (en) | 2006-05-31 | 2007-12-06 | Abbott Laboratories | Compounds as cannabinoid receptor ligands and uses thereof |
| US8841334B2 (en) | 2006-05-31 | 2014-09-23 | Abbvie Inc. | Compounds as cannabinoid receptor ligands and uses thereof |
| US7875640B2 (en) | 2007-03-28 | 2011-01-25 | Abbott Laboratories | Compounds as cannabinoid receptor ligands |
| US7872033B2 (en) | 2007-04-17 | 2011-01-18 | Abbott Laboratories | Compounds as cannabinoid receptor ligands |
| EP2160393A1 (en) | 2007-05-18 | 2010-03-10 | Abbott Laboratories | Novel compounds as cannabinoid receptor ligands |
| KR100863239B1 (ko) | 2007-05-23 | 2008-10-15 | 한국과학기술연구원 | 신규한 2-이미노-1,3-티아졸린계 화합물 및 이를 함유하는ｔ-형 칼슘 채널 저해제 |
| US9193713B2 (en) | 2007-10-12 | 2015-11-24 | Abbvie Inc. | Compounds as cannabinoid receptor ligands |
| CN102076672A (zh) * | 2008-04-25 | 2011-05-25 | 大日本住友制药株式会社 | 新型五元环化合物 |
| CN102076682A (zh) * | 2008-04-25 | 2011-05-25 | 大日本住友制药株式会社 | 五元环化合物 |
| US8846730B2 (en) | 2008-09-08 | 2014-09-30 | Abbvie Inc. | Compounds as cannabinoid receptor ligands |
| BRPI0919135A2 (pt) | 2008-09-16 | 2015-12-08 | Abbott Lab | compostos inéditos como ligantes do receptor canabinóide. |
| PA8854001A1 (es) | 2008-12-16 | 2010-07-27 | Abbott Lab | Compuestos novedosos como ligandos de receptores de canabinoides |
| EP2411382A1 (en) | 2009-03-27 | 2012-02-01 | Abbott Laboratories | Compounds as cannabinoid receptor ligands |
| US9650369B2 (en) * | 2012-09-28 | 2017-05-16 | Xavier University Of Louisiana | Anti-migration and anti-invasion thiazole analogs for treatment of cellular proliferative disease |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE941288C (de) * | 1950-10-31 | 1956-04-05 | Goodrich Co B F | Verfahren zur Herstellung substituierter 2-Imino-4-thiazoline oder von Salzen derselben bzw. von substituierten 2-Aminothiazolen |
| EP0848059A1 (en) | 1996-12-12 | 1998-06-17 | Vetigen | Mammalian ICYP (Iodocyanopindolol) receptor and its applications |
| US7076307B2 (en) * | 2002-05-09 | 2006-07-11 | Boveja Birinder R | Method and system for modulating the vagus nerve (10th cranial nerve) with electrical pulses using implanted and external components, to provide therapy neurological and neuropsychiatric disorders |
| FR2796643B1 (fr) * | 1999-07-22 | 2005-04-29 | Sod Conseils Rech Applic | Derives de 2-arylimino-2, 3-dihydrothiazoles, leurs procedes de preparation et leur utilisation therapeutique |
| CA2389773A1 (en) * | 1999-11-05 | 2001-05-10 | Robert Glen | Activators of soluble guanylate cyclase |
| US20030208212A1 (en) * | 1999-12-07 | 2003-11-06 | Valerio Cigaina | Removable gastric band |
| DE19959825C1 (de) * | 1999-12-10 | 2001-07-26 | Dorma Gmbh & Co Kg | Schiebewand mit mehreren seitlich verschiebbaren Wandelementen |
| US6885888B2 (en) * | 2000-01-20 | 2005-04-26 | The Cleveland Clinic Foundation | Electrical stimulation of the sympathetic nerve chain |
| US6708064B2 (en) * | 2000-02-24 | 2004-03-16 | Ali R. Rezai | Modulation of the brain to affect psychiatric disorders |
| US6639077B2 (en) * | 2000-03-23 | 2003-10-28 | Merck Frosst Canada & Co. | Tri-aryl-substituted-ethane PDE4 inhibitors |
| US6684105B2 (en) * | 2001-08-31 | 2004-01-27 | Biocontrol Medical, Ltd. | Treatment of disorders by unidirectional nerve stimulation |
| US7054686B2 (en) * | 2001-08-30 | 2006-05-30 | Biophan Technologies, Inc. | Pulsewidth electrical stimulation |
| EP1476221A4 (en) * | 2002-02-01 | 2008-04-23 | Cleveland Clinic Foundation | ADJUSTABLE SIMULATION DEVICE AND USE METHOD THEREFOR |
| US20050010262A1 (en) * | 2002-02-01 | 2005-01-13 | Ali Rezai | Modulation of the pain circuitry to affect chronic pain |
| CA2474926A1 (en) * | 2002-02-01 | 2003-08-14 | Ali Rezai | Neural stimulation delivery device with independently moveable delivery structures |
| US7689276B2 (en) * | 2002-09-13 | 2010-03-30 | Leptos Biomedical, Inc. | Dynamic nerve stimulation for treatment of disorders |
| US20040015205A1 (en) * | 2002-06-20 | 2004-01-22 | Whitehurst Todd K. | Implantable microstimulators with programmable multielectrode configuration and uses thereof |
| US7292890B2 (en) * | 2002-06-20 | 2007-11-06 | Advanced Bionics Corporation | Vagus nerve stimulation via unidirectional propagation of action potentials |
| US20040210270A1 (en) * | 2002-07-26 | 2004-10-21 | John Erickson | High frequency pulse generator for an implantable neurostimulator |
| US7209790B2 (en) * | 2002-09-30 | 2007-04-24 | Medtronic, Inc. | Multi-mode programmer for medical device communication |
| US7844338B2 (en) * | 2003-02-03 | 2010-11-30 | Enteromedics Inc. | High frequency obesity treatment |
| US20040172084A1 (en) * | 2003-02-03 | 2004-09-02 | Knudson Mark B. | Method and apparatus for treatment of gastro-esophageal reflux disease (GERD) |
| US7613515B2 (en) * | 2003-02-03 | 2009-11-03 | Enteromedics Inc. | High frequency vagal blockage therapy |
| US7167750B2 (en) * | 2003-02-03 | 2007-01-23 | Enteromedics, Inc. | Obesity treatment with electrically induced vagal down regulation |
| US7444184B2 (en) * | 2003-05-11 | 2008-10-28 | Neuro And Cardial Technologies, Llc | Method and system for providing therapy for bulimia/eating disorders by providing electrical pulses to vagus nerve(s) |
| US7149574B2 (en) * | 2003-06-09 | 2006-12-12 | Palo Alto Investors | Treatment of conditions through electrical modulation of the autonomic nervous system |
| US7263405B2 (en) * | 2003-08-27 | 2007-08-28 | Neuro And Cardiac Technologies Llc | System and method for providing electrical pulses to the vagus nerve(s) to provide therapy for obesity, eating disorders, neurological and neuropsychiatric disorders with a stimulator, comprising bi-directional communication and network capabilities |
| US7617002B2 (en) * | 2003-09-15 | 2009-11-10 | Medtronic, Inc. | Selection of neurostimulator parameter configurations using decision trees |
| US7239926B2 (en) * | 2003-09-15 | 2007-07-03 | Medtronic, Inc. | Selection of neurostimulator parameter configurations using genetic algorithms |
| US7184837B2 (en) * | 2003-09-15 | 2007-02-27 | Medtronic, Inc. | Selection of neurostimulator parameter configurations using bayesian networks |
| US7252090B2 (en) * | 2003-09-15 | 2007-08-07 | Medtronic, Inc. | Selection of neurostimulator parameter configurations using neural network |
| US7418292B2 (en) * | 2003-10-01 | 2008-08-26 | Medtronic, Inc. | Device and method for attenuating an immune response |
| EP1781372A1 (en) * | 2004-07-20 | 2007-05-09 | Medtronic, Inc. | Therapy programming guidance based on stored programming history |
-
2001
- 2001-06-28 CN CNB018146139A patent/CN100369903C/zh not_active Expired - Fee Related
- 2001-06-28 CN CNA2006100818928A patent/CN1944417A/zh active Pending
- 2001-06-28 AT AT01943850T patent/ATE451102T1/de active
- 2001-06-28 EP EP05025661A patent/EP1669070A3/en not_active Withdrawn
- 2001-06-28 AU AU6634501A patent/AU6634501A/xx active Pending
- 2001-06-28 JP JP2002507796A patent/JP3785397B2/ja not_active Expired - Fee Related
- 2001-06-28 KR KR1020077015693A patent/KR100824156B1/ko not_active IP Right Cessation
- 2001-06-28 KR KR1020027017947A patent/KR100758775B1/ko not_active IP Right Cessation
- 2001-06-28 EP EP01943850A patent/EP1300401B1/en not_active Expired - Lifetime
- 2001-06-28 US US10/312,692 patent/US6919361B2/en not_active Expired - Fee Related
- 2001-06-28 DE DE60140748T patent/DE60140748D1/de not_active Expired - Lifetime
- 2001-06-28 ES ES01943850T patent/ES2336425T3/es not_active Expired - Lifetime
- 2001-06-28 PT PT01943850T patent/PT1300401E/pt unknown
- 2001-06-28 AU AU2001266345A patent/AU2001266345B2/en not_active Ceased
- 2001-06-28 WO PCT/JP2001/005540 patent/WO2002002542A1/ja active Application Filing
- 2001-06-28 DK DK01943850.6T patent/DK1300401T3/da active
- 2001-06-28 CA CA002413000A patent/CA2413000C/en not_active Expired - Fee Related
- 2001-06-29 TW TW090115944A patent/TWI313266B/zh not_active IP Right Cessation
-
2005
- 2005-04-22 US US11/111,845 patent/US7396842B2/en not_active Expired - Fee Related
-
2010
- 2010-03-02 CY CY20101100202T patent/CY1109863T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1944417A (zh) | 2007-04-11 |
| EP1300401B1 (en) | 2009-12-09 |
| US7396842B2 (en) | 2008-07-08 |
| KR100758775B1 (ko) | 2007-09-14 |
| KR20030011377A (ko) | 2003-02-07 |
| CA2413000C (en) | 2010-01-19 |
| ES2336425T3 (es) | 2010-04-13 |
| EP1300401A1 (en) | 2003-04-09 |
| US20050222226A1 (en) | 2005-10-06 |
| US20040072827A1 (en) | 2004-04-15 |
| DK1300401T3 (da) | 2010-02-01 |
| KR100824156B1 (ko) | 2008-04-21 |
| KR20070086998A (ko) | 2007-08-27 |
| CY1109863T1 (el) | 2014-09-10 |
| EP1669070A3 (en) | 2007-05-23 |
| EP1669070A2 (en) | 2006-06-14 |
| WO2002002542A1 (en) | 2002-01-10 |
| CA2413000A1 (en) | 2002-01-10 |
| DE60140748D1 (de) | 2010-01-21 |
| EP1300401A4 (en) | 2004-07-21 |
| ATE451102T1 (de) | 2009-12-15 |
| CN100369903C (zh) | 2008-02-20 |
| AU6634501A (en) | 2002-01-14 |
| AU2001266345B2 (en) | 2006-03-02 |
| US6919361B2 (en) | 2005-07-19 |
| CN1620442A (zh) | 2005-05-25 |
| TWI313266B (en) | 2009-08-11 |
| JP3785397B2 (ja) | 2006-06-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1109863T1 (el) | Παραγωγα θειαζολης για χρηση ως αντιφλεγμονωδη | |
| GB2287023B (en) | Dioxolane intermediates | |
| EP1310494A4 (en) | PPAR-DELTA ACTIVATORS | |
| WO2003016291A1 (fr) | Activateur du recepteur $g(d) sensible au proliferateur de peroxysome | |
| HK1003000A1 (en) | Spiro compounds | |
| GB9624038D0 (en) | Organic compounds | |
| DE69918695D1 (de) | Sauerstoffhaltige heterocyclische verbindungen | |
| EP0214732A3 (en) | (substituted benzyl)-thio heterocyclic compounds having a leukotriene-antagonist activity | |
| AU670154B2 (en) | Modified oligodeoxyribonucleotides, their preparation and their therapeutic use | |
| ES2065994T3 (es) | Beta-dicetonas substituidas. | |
| BG105123A (en) | Tetrahydroquinaline derivatives as glycine antagonists | |
| EP0407621A4 (en) | Benzothiazole derivatives | |
| IE902272L (en) | Compositions of 5-phenyl-2-furan ketones | |
| DK0413278T3 (da) | Anvendelse af xanthinderivater mod mavesår | |
| DK0583806T3 (da) | Acrylderivater af 2-thiazolylpyrroler med fungicid aktivitet | |
| TH55756B (th) | สารประกอบอิมิดาโซลที่เป็นเสมือนด้วยยับยั้งฟอสโฟไดเอสเทอเรส vii |